Keywords: Johnson & Johnson, Job cuts, Global Restructuring, Generic erosion

Johnson & Johnson to shed 6%-7% of jobs; confirms 2009 guidance

Article | 04 November 2009

Print This

Following in the path of drug majors such as Pfizer, Bristol-Myers Squibb, GlaxoSmithKline and AstraZeneca, US health care giant Johnson & ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in